ulbi20160722_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 
 

FORM 8-K

 
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
 

July 28, 2016

(Date of Report)

 
 

ULTRALIFE CORPORATION

(Exact name of registrant as specified in its charter)

 
 
 

Delaware

000-20852

16-1387013

(State of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

          2000 Technology Parkway, Newark, New York

14513

          (Address of principal executive offices)

(Zip Code)

 

(315) 332-7100

(Registrant’s telephone number, including area code)

 
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

 

Item 2.02           Results of Operations and Financial Condition

 

 

NEWARK, N.Y. – July 28, 2016 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.5 million on revenue of $20.4 million for the second quarter ended June 26, 2016. For the second quarter of 2015, the Company reported operating income of $0.8 million on revenue of $19.0 million.

 

“Through solid execution of our business model parameters including close control of spending in a challenging economic environment, we delivered profitability for the seventh consecutive quarter and generated positive cash flow,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer. “Despite some economic uncertainties weighing on customer’s buying decisions, we still have our sights set on delivering profitable growth for 2016. Our gross margins and liquidity give us the flexibility to continue to invest in new product development in support of our long-term global diversification strategy.”

 

Revenue was $20.4 million, an increase of $1.4 million, or 7%, compared to $19.0 million for the second quarter of 2015 reflecting the addition of Accutronics and higher Communications Systems sales. Battery & Energy Products sales were $15.8 million compared to $16.0 million last year, reflecting the contribution of Accutronics sales which offset the revenue reduction resulting from a large 9-Volt and large metering and toll pass battery orders in the second quarter of 2015. Communications Systems sales grew 55% to $4.6 million compared to $3.0 million for the same period last year as a result of shipments under the Vehicle Installed Power Enhanced Riflemen Appliqué (“VIPER”) Program.

 

Gross profit was $5.9 million, or 29.0% of revenue, compared to $5.9 million, or 30.9% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 29.6%, compared to 28.4% last year, an increase of 120 basis points reflecting favorable product mix including the contribution of Accutronics. Communications Systems’ gross margin declined to 26.8% compared to 44.2% for the prior year due to sales mix.

 

Operating expenses were $5.4 million compared to $5.0 million last year reflecting the addition of Accutronics and increased spending on new product development in response to a higher level of proposal activity, partially offset by tight control over discretionary spending. Operating expenses were 26.5% of revenue compared to 26.6% of revenue for the year earlier period.

 

Operating income was $0.5 million compared to $0.8 million last year.

 

Net income was $0.4 million, or $0.03 per share, compared to a net income of $0.8 million, or $0.05 per share, for the second quarter of 2015.

 

 

The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed as incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.

 

 
 

 

 

Item 9.01     Financial Statements, Pro Forma Financials and Exhibits

 

(a) Exhibits.

 

Exhibit

Number

____________________Description___________________________

 

99.1

Press Release of Ultralife Corporation dated July 28, 2016.

 

 
 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: July 28, 2016

 

ULTRALIFE Corporation

     
     
 

By:

/s/ Philip A. Fain

   

Philip A. Fain

   

Chief Financial Officer and Treasurer

     
     

 

 

 
 

 

 

EXHIBIT INDEX

 

Exhibit

Number

___________________ _Description___________________________

 

99.1

Press Release of Ultralife Corporation dated July 28, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ex99-1.htm

Exhibit 99.1

 

 

Company Contact:     

Investor Relations Contact:

Ultralife Corporation   

LHA

Philip A. Fain    Jody Burfening
(315) 210-6110    (212) 838-3777
pfain@ulbi.com jburfening@lhai.com

 

 

                              

                               

Ultralife Corporation Reports Second Quarter Results

 

 

NEWARK, N.Y. – July 28, 2016 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.5 million on revenue of $20.4 million for the second quarter ended June 26, 2016. For the second quarter of 2015, the Company reported operating income of $0.8 million on revenue of $19.0 million.

 

“Through solid execution of our business model parameters including close control of spending in a challenging economic environment, we delivered profitability for the seventh consecutive quarter and generated positive cash flow,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer. “Despite some economic uncertainties weighing on customer’s buying decisions, we still have our sights set on delivering profitable growth for 2016. Our gross margins and liquidity give us the flexibility to continue to invest in new product development in support of our long-term global diversification strategy.”

 

 

Second Quarter 2016 Financial Results

 

Revenue was $20.4 million, an increase of $1.4 million, or 7%, compared to $19.0 million for the second quarter of 2015 reflecting the addition of Accutronics and higher Communications Systems sales. Battery & Energy Products sales were $15.8 million compared to $16.0 million last year, reflecting the contribution of Accutronics sales which offset the revenue reduction resulting from a large 9-Volt and large metering and toll pass battery orders in the second quarter of 2015. Communications Systems sales grew 55% to $4.6 million compared to $3.0 million for the same period last year as a result of shipments under the Vehicle Installed Power Enhanced Riflemen Appliqué (“VIPER”) Program.

 

Gross profit was $5.9 million, or 29.0% of revenue, compared to $5.9 million, or 30.9% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 29.6%, compared to 28.4% last year, an increase of 120 basis points reflecting favorable product mix including the contribution of Accutronics. Communications Systems’ gross margin declined to 26.8% compared to 44.2% for the prior year due to sales mix.

 

 
 

 

 

Operating expenses were $5.4 million compared to $5.0 million last year reflecting the addition of Accutronics and increased spending on new product development in response to a higher level of proposal activity, partially offset by tight control over discretionary spending. Operating expenses were 26.5% of revenue compared to 26.6% of revenue for the year earlier period.

 

Operating income was $0.5 million compared to $0.8 million last year.

 

Net income was $0.4 million, or $0.03 per share, compared to a net income of $0.8 million, or $0.05 per share, for the second quarter of 2015.

 

 

Share Repurchase Program

 

The Company’s Share Repurchase Program expired on June 2, 2016. From the inception of the Program on May 1, 2014 through its expiration, the Company repurchased 2,592,095 shares for an aggregate cost of $10.5 million.

 

 

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

 

 

 

Conference Call Information

 

Ultralife will hold its second quarter earnings conference call today at 10:00 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

 

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 

 
 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

 
                 

ASSETS

   

June 26,

   

December 31,

 
   

2016

   

2015

 

Current Assets:

               

Cash and Cash Equivalents

  $ 3,262     $ 14,533  

Trade Accounts Receivable, Net

    13,735       11,430  

Inventories

    26,553       23,814  

Prepaid Expenses and Other Current Assets

    2,440       2,169  

Total Current Assets

    45,990       51,946  
                 

Property, Equipment and Improvements, Net

    8,858       9,038  

Goodwill, Intangibles and Other Assets

    28,450       20,538  

Total Assets

  $ 83,298     $ 81,522  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

               

Accounts Payable

  $ 6,654     $ 6,494  

Accrued Compensation and Related Benefits

    1,818       2,377  

Accrued Expenses and Other Current Liabilities

    2,570       1,976  

Current Portion of Debt

    831       -  

Total Current Liabilities

    11,873       10,847  

Deferred Income Taxes and Other Non-Current Liabilities

    5,569       4,659  

Total Liabilities

    17,442       15,506  
                 

Shareholders' Equity:

               

Common Stock

    1,920       1,918  

Capital in Excess of Par Value

    177,430       177,007  

Accumulated Deficit

    (93,306 )     (94,051 )

Accumulated Other Comprehensive Loss

    (1,608 )     (907 )

Treasury Stock

    (18,415 )     (17,808 )

Total Ultralife Equity

    66,021       66,159  

Non-Controlling Interest

    (165 )     (143 )

Total Shareholders’ Equity

    65,856       66,016  
                 

Total Liabilities and Shareholders' Equity

  $ 83,298     $ 81,522  

 

 
 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)

(Unaudited)

                                 
   

Three Month Periods Ended

   

Six Month Periods Ended

 
   

June 26,

   

June 28,

   

June 26,

   

June 28,

 
   

2016

   

2015

   

2016

   

2015

 

Revenues:

                               

Battery & Energy Products

  $ 15,759     $ 15,972     $ 32,199     $ 32,248  

Communication Systems

    4,612       2,983       9,005       5,884  

Total Revenues

    20,371       18,955     $ 41,204     $ 38,132  
                                 

Cost of Products Sold:

                               

Battery & Energy Products

    11,095       11,430       22,318       22,922  

Communication Systems

    3,376       1,666       6,581       3,344  

Total Cost of Products Sold

    14,471       13,096       28,899       26,266  
                                 

Gross Profit

    5,900       5,859       12,305       11,866  
                                 

Operating Expenses:

                               

Research and Development

    1,425       1,334       3,081       2,693  

Selling, General and Administrative

    3,976       3,708       8,243       7,534  

Total Operating Expenses

    5,401       5,042       11,324       10,227  
                                 

Operating Income

    499       817       981       1,639  
                                 

Other Income (Expense)

    (24 )     28       (137 )     (160 )

Income Before Income Taxes

    475       845       844       1,479  
                                 

Income Tax Provision

    33       71       121       182  
                                 

Net Income

    442       774       723       1,297  
                                 

Net Loss Attributable to Non-Controlling Interest

    4       14       22       24  
                                 

Net Income Attributable to Ultralife Corporation

  $ 446     $ 788     $ 745     $ 1,321  
                                 
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders – Basic

  $ .03     $ .05     $ .05     $ .08  
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted

  $ .03     $ .05     $ .05     $ .08  
                                 

Weighted Average Shares Outstanding – Basic

    15,258       16,557       15,290       16,945  
                                 

Weighted Average Shares Outstanding – Diluted

    15,419       16,597       15,545       16,977